Market Research Logo

NRT Smoking Cessation Aids in Belgium

NRT Smoking Cessation Aids in Belgium

After two lean years, NRT smoking cessation aids operators enjoyed robust current value growth in 2016 and 2017 and could even hope for a favourable outlook over 2017-2022. Whilst it was later to take off in Belgium than in other countries, the niche of e-cigarettes (not included in consumer health) was suspected of cannibalising sales of NRT smoking cessation aids over 2014/2015. However, it did not do as well over 2016/2017. First, just six months after authorising the sale of vapour devices i...

Euromonitor International's NRT Smoking Cessation Aids in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.


NRT SMOKING CESSATION AIDS IN BELGIUM
Euromonitor International
October 2017
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Tougher Regulations on E-liquids and Packaging Seen As good News for Nrt Smoking Cessation Aids
Higher Prices for A Pack of Cigarettes Also Offers Growth Potential for the Category
Winning Formats: Everything But the Patches
Competitive Landscape
Janssen-cilag Increasingly Drives Sales
Niquitin Still Not Thriving and Nicotinell Still Unable To Surge Against Nicorette
Focus on Tactical Advertising Rather Than Innovation
Category Indicators
Table 1 Number of Smokers by Gender 2012-2017
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Table 4 Sales of NRT Gum by Flavour: % Value 2012-2017
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Executive Summary
2017 Is Almost A Year To Forget for Consumer Health
Manufacturers Are Playing A Cat-and-mouse Game With Local and European Authorities
Ethical Multinationals Find It Difficult To Face the Aggressiveness of Local Players
Chemists/pharmacies Largely Dominate But Lose Ground
Possible Soft Blow for Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 10 Life Expectancy at Birth 2012-2017
Market Data
Table 11 Sales of Consumer Health by Category: Value 2012-2017
Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Definitions
Sources
Summary 2 Research Sources
Executive Summary
2017 Is Almost A Year To Forget for Consumer Health
Manufacturers Are Playing A Cat-and-mouse Game With Local and European Authorities
Ethical Multinationals Find It Difficult To Face the Aggressiveness of Local Players
Chemists/pharmacies Largely Dominate But Lose Ground
Possible Soft Blow for Consumer Health
Market Indicators
Table 20 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 21 Life Expectancy at Birth 2012-2017
Market Data
Table 22 Sales of Consumer Health by Category: Value 2012-2017
Table 23 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 24 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 25 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 26 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 27 Distribution of Consumer Health by Format: % Value 2012-2017
Table 28 Distribution of Consumer Health by Format and Category: % Value 2017
Table 29 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 30 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 3 OTC: Switches 2016-2017
Definitions
Sources
Summary 4 Research Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report